Trius Therapeutics Inc - FORM S-1 - EX-23.1 - CONSENT OF ERNST & YOUNG LLP - June 21, 2011

Attached files

file filename
S-1 - FORM S-1 - Trius Therapeutics Incds1.htm
EX-4.7 - AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT - Trius Therapeutics Incdex47.htm
EX-5.1 - OPINION OF COOLEY LLP - Trius Therapeutics Incdex51.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 24, 2011 in the Registration Statement (Form S-1) and related Prospectus of Trius Therapeutics, Inc. for the registration of 6,412,500 shares of its common stock.

 

/s/ Ernst & Young LLP

San Diego, California

June 21, 2011

Trius Therapeutics Inc Reports